Effect of RNS60 on the Late Phase Asthmatic Response to Allergen Challenge

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The study will investigate the effect of treatment with RNS60 for 21 days. Subjects\' FEV1 will be measured after an inhaled allergen challenge at baseline and again after 21 days of treatment.
Epistemonikos ID: 099538a4f44c5714dc3323f713065da960a94928
First added on: May 12, 2024